首页> 美国卫生研究院文献>Journal of the Royal Society Interface >The role of modelling in identifying drug targets for diseases of the cell cycle
【2h】

The role of modelling in identifying drug targets for diseases of the cell cycle

机译:模型在确定细胞周期疾病药物靶点中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The cell cycle is implicated in diseases that are the leading cause of mortality and morbidity in the developed world. Until recently, the search for drug targets has focused on relatively small parts of the regulatory network under the assumption that key events can be controlled by targeting single pathways. This is valid provided the impact of couplings to the wider scale context of the network can be ignored. The resulting depth of study has revealed many new insights; however, these have been won at the expense of breadth and a proper understanding of the consequences of links between the different parts of the network. Since it is now becoming clear that these early assumptions may not hold and successful treatments are likely to employ drugs that simultaneously target a number of different sites in the regulatory network, it is timely to redress this imbalance. However, the substantial increase in complexity presents new challenges and necessitates parallel theoretical and experimental approaches. We review the current status of theoretical models for the cell cycle in light of these new challenges. Many of the existing approaches are not sufficiently comprehensive to simultaneously incorporate the required extent of couplings. Where more appropriate levels of complexity are incorporated, the models are difficult to link directly to currently available data. Further progress requires a better integration of experiment and theory. New kinds of data are required that are quantitative, have a higher temporal resolution and that allow simultaneous quantitative comparison of the concentration of larger numbers of different proteins. More comprehensive models are required and must accommodate not only substantial uncertainties in the structure and kinetic parameters of the networks, but also high levels of ignorance. The most recent results relating network complexity to robustness of the dynamics provide clues that suggest progress is possible.
机译:细胞周期与疾病有关,这些疾病是发达国家死亡和发病的主要原因。直到最近,在假设关键事件可以通过靶向单一途径来控制的前提下,对药物靶点的搜索一直集中在监管网络的相对较小部分。如果可以忽略耦合对网络更广泛范围的影响,则这是有效的。由此产生的深入研究揭示了许多新见解。但是,以牺牲广度和对网络不同部分之间链接的后果的正确理解为代价赢得了这些大奖。由于现在已经清楚这些早期假设可能不成立,并且成功的治疗方法很可能会采用同时针对监管网络中多个不同位置的药物,因此,现在应该纠正这种不平衡。但是,复杂性的显着增加提出了新的挑战,并且需要并行的理论和实验方法。根据这些新挑战,我们回顾了细胞周期理论模型的现状。许多现有方法不够全面,无法同时纳入所需范围的联轴器。如果结合了更适当的复杂性级别,则很难将模型直接链接到当前可用数据。进一步的进步需要更好地整合实验和理论。需要新的数据类型,这些数据必须是定量的,具有较高的时间分辨率,并且可以同时定量比较大量不同蛋白质的浓度。需要更全面的模型,不仅要适应网络结构和动力学参数的实质性不确定性,还要适应高水平的无知。将网络复杂性与动态鲁棒性相关的最新结果提供了暗示可能取得进展的线索。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号